NIR-II light-driven transformable nanomedicine for precise deep-tissue photothermal therapy

Photothermal therapy (PTT) holds potential as a noninvasive cancer treatment but is challenged by limited tissue penetration due to physiological barriers. Here, we report that conditional extracellular matrix proteolysis augments deep-tissue PTT using a NIR-II light-activatable biomineralized material. We demonstrate specific photothermic manipulation of biomineralized nanoarchitectures by encapsulating gold nanostars and the thermozyme bromelain into nanoframework for spatially controlled tumor stroma remodeling. This transformable nanomedicine allows active transport and effective particle accumulation via stromal-targeting ligand and subsequent therapeutics release in response to microenvironment, which exposes thermozyme and photothermal agent with spiky surface and smaller size that can facilitate cellular internalization and penetration. Notably, light-initiated hyperthermia-activated thermozyme induces in situ degradation of key extracellular matrix scaffold for tumor-specific stroma barrier breaking, and thus synergizes with NIR-II thermoplasmonics to access cancer cells at deep sites. This approach significantly enhances tumor accumulation and penetration to potentiates photothermal ablation in different tumor models, showing inhibitory rate up to 98.9%. Compared to NIR-II PTT incapable of stroma breakdown, our method leveraging NIR-II thermoplasmonics and thermozyme achieves folds increase in antitumor efficacy using murine model. These findings may facilitate efforts to design spatiotemporal controllable agents for safe and effective therapy.